Becton Dickinson and Co at JPMorgan Healthcare Conference Transcript
Good morning, everyone. I'm Robbie Marcus, med tech analyst at JPMorgan. Really happy to kick off day 2 of the Healthcare Conference. We're starting off with a presentation by Becton, Dickinson. I'd like to introduce Tom Polen, the CEO, do a quick presentation, then I'll join on with some others from the company for some Q&A.
Tom?
Okay. Thank you, Robbie. Okay. Good morning, everyone. And again, thank you, Robbie. We appreciate everyone's interest in BD. I'm pleased to update you today on the strong progress we have made advancing our BD 2025 strategic goals. This includes consistently exceeding our durable 5.5% revenue growth profile and driving 3-year base organic revenue growth of nearly 7%, inclusive of our FY '24 guidance. This has been achieved by systematically shifting our portfolio into higher growth spaces, both organically through CapEx and R&D, and inorganically through M&A
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
